Valuation: Treace Medical Concepts, Inc.

Market Cap 297M 254M 237M 217M 409M 28.38B 417M 2.81B 1.1B 14.21B 1.11B 1.09B 47.14B P/E 2026 *
-5.36x
P/E 2027 * -5.89x
Enterprise Value 342M 293M 274M 251M 472M 32.75B 481M 3.24B 1.26B 16.4B 1.28B 1.26B 54.4B EV / Sales 2026 *
1.65x
EV / Sales 2027 * 1.73x
Free-Float
74.51%
Yield 2026 *
-
Yield 2027 * -
1 day-2.19%
1 week-6.11%
Current month+3.48%
1 month+3.72%
3 months+63.97%
6 months+132.29%
Current year+82.04%
1 week 4.3
Extreme 4.3
4.79
1 month 3.85
Extreme 3.85
5.2
Current year 1.17
Extreme 1.17
5.2
1 year 1.17
Extreme 1.17
7.78
3 years 1.17
Extreme 1.17
16.67
5 years 1.17
Extreme 1.17
31.02
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 2013-06-30
Director of Finance/CFO 56 2020-08-31
Chief Tech/Sci/R&D Officer - 2022-02-28
Director TitleAgeSince
Chairman 54 2025-05-19
Director/Board Member 65 2020-11-19
Director/Board Member 68 2020-11-19
Date Insider Type Main position Quantity % Market Cap.
8/9/26 Tax

Chief Financial Officer

-37,102 0.0572%
8/9/26 Tax

Responsable ventes & marketing

-9,814 0.0151%
8/9/26 Tax

Compliance Officer

-16,253 0.0251%
Change 5-day change 1-year change 3-year change Capi.($)
-2.19%-6.11%-37.97%-73.33% 297M
-0.94%-0.86%+27.87%+28.88% 12.87B
+0.82%+2.84%+19.35%+34.70% 7.03B
+3.83%+5.37%+54.40%+50.48% 6.65B
-0.20%-2.51% - - 5.68B
+16.51%+23.25%-7.18%+88.91% 4.73B
+1.51%-2.67%-27.01%-22.00% 3.84B
-2.36%+1.02%+47.22%-42.77% 2.12B
+0.16%-6.50%+46.61%-8.84% 1.62B
+1.31%+2.65%-33.17%+124.90% 1.6B
Average +1.84%+1.70%+10.01%+20.10% 4.64B
Weighted average by Cap. +2.12%+2.41%+20.37%+33.39%

Financials

2026 *2027 *
Net sales 207M 178M 166M 152M 286M 19.85B 292M 1.97B 766M 9.94B 779M 762M 32.98B 222M 190M 177M 163M 306M 21.22B 312M 2.1B 819M 10.63B 833M 814M 35.25B
Net income -55.26M -47.3M -44.21M -40.53M -76.18M -5.29B -77.67M -524M -204M -2.65B -207M -203M -8.79B -51.01M -43.66M -40.8M -37.41M -70.31M -4.88B -71.69M -483M -188M -2.44B -192M -187M -8.11B
Net Debt 45.67M 39.09M 36.53M 33.49M 62.95M 4.37B 64.18M 433M 169M 2.19B 171M 168M 7.26B 86.44M 73.98M 69.14M 63.39M 119M 8.27B 121M 819M 319M 4.14B 325M 317M 13.74B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
26-08-20 US$4.460 -2.19% 270,846
26-08-19 US$4.560 +2.47% 398,356
26-08-18 US$4.450 -1.11% 227,164
26-08-17 US$4.500 -6.05% 193,260
26-08-14 US$4.790 +6.21% 245,390
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.460USD
Average target price
5.500USD
Spread / Average Target
+23.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock